Mark C. Chappell

224 papers receiving 17.0k citations

Mark C. Chappell's Hit Papers

COVID-19, ACE2, and the cardiovascular consequences 2020 · 586 citations
5860+8+16Years since publication50010001.5k2.0k2.5k

Peers

Mark C. Chappell
Comparison fields: 5 of 153
  • Cardiology and Cardiovascular Medicine 8.1k
  • Endocrinology, Diabetes and Metabolism 5.1k
  • Infectious Diseases 4.5k
  • Obstetrics and Gynecology 1.1k
  • Pharmacology 1.9k
Replace Gavin Y. Oudit with:
Gavin Y. Oudit Canada
Robson A.S. Santos Brazil
Mohan K. Raizada United States
Carlos Maria Ferrario United States
Curt D. Sigmund United States
Louise Burrell Australia
Lutz Hein Germany
Thomas Walther Germany
Roberto Vettor Italy
François N. Pattou France
Mark C. Chappell relative to Gavin Y. Oudit Canada Gavin Y. Oudit's profile →
Citations per field
00.5×1.5×2.0×
Gavin Y. Oudit · 1×
Citations per year

Countries citing papers authored by Mark C. Chappell

Since Specialization
Citations

This map shows the geographic impact of Mark C. Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Chappell more than expected).

Fields of papers citing papers by Mark C. Chappell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Chappell. The network helps show where Mark C. Chappell may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark C. Chappell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark C. Chappell Line = papers co-authored together Mark C. Chappell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 229 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Hit paper breakdown →
20052747
2
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Hit paper breakdown →
20021471
3
Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2
Hit paper breakdown →
20051298
4
COVID-19, ACE2, and the cardiovascular consequences
Hit paper breakdown →
2020586
5 1997444
6 2009275
7 1998267
8 1999260
9 1998250
10 2000239
11 2015237
12 2005234
13 1997223
14 2007210
15 1998206
16 1998204
17 1989199
18 2007184
19 1998179
20 2007175

About Mark C. Chappell

Mark C. Chappell is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 229 papers that have together received 17.5k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (127 papers), Hormonal Regulation and Hypertension (79 papers), Receptor Mechanisms and Signaling (45 papers), Birth, Development, and Health (31 papers), Apelin-related biomedical research (22 papers), Pregnancy and preeclampsia studies (20 papers), Estrogen and related hormone effects (15 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.1k citations), Endocrinology, Diabetes and Metabolism (5.1k citations), Infectious Diseases (4.5k citations), Obstetrics and Gynecology (1.1k citations) and Pharmacology (1.9k citations). Mark C. Chappell has collaborated with scholars based in United States, Egypt and Germany. Frequent co-authors include Carlos Maria Ferrario, Debra I. Diz, K. Bridget Brosnihan, Patricia E. Gallagher, David B. Averill, Elisabeth Ann Tallant, Jewell A. Jessup, Andrew Michael South, K. Bridget Brosnihan and Sarah Hoffmann Lindsey. Their work appears in journals such as Hypertension, The FASEB Journal, American Journal of Physiology-Renal Physiology, Peptides and American Journal of Physiology-Heart and Circulatory Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact